Table 2 Cases of CIDP associated with Crohn's disease
Reference | Age/Sex | IBD activity | Gap | IBD treatment | CIDP treatment |
|---|---|---|---|---|---|
our case | 18/M | CA | −7 months | none | IVIG |
6 | 60/F | RR | 30 years | TNF-α antagonist (infliximab) | IVIG, prednisolone, azathioprine |
7 | 49/M | Q | 20 years | none | IVIG, plasmapheresis, fludarabine, methotrexate |
7 | 47/F | RR | 1 years | etanercept, prednisolone | IVIG, prednisolone, plasmapheresis |
7 | 50/M | RR | 23 years | azathioprine | IVIG, prednisolone |
8 | 36/M | CA | 4 years | mesalazine, metronidazole, ciprofloxacin, azathioprine | Plasmapheresis, prednisolone |
9 | 32/M | CA | 0 year | none (newly diagnosed) | IVIG, prednisolone, azathioprine |
10 | 63/F | CA | 0 year | none (newly diagnosed) | IVIG, prednisolone |